
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 1037 | 203.00 | 203.25 | 22 |
| 375 | 202.75 | 203.45 | 572 |
| 10 | 202.50 | 203.50 | 1122 |
| 211 | 202.40 | 203.55 | 450 |
| 223 | 202.35 | 203.60 | 50 |
| 0 | Total | Total | 0 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 1037 | 203.00 | 203.25 | 22 |
| 375 | 202.75 | 203.45 | 572 |
| 10 | 202.50 | 203.50 | 1122 |
| 211 | 202.40 | 203.55 | 450 |
| 223 | 202.35 | 203.60 | 50 |
| 0 | Total | Total | 0 |
As on --
(OI , PRICE )
As on --
| Open | 203.10 |
| Previous Close | 203.14 |
| Volume | 2,176,419.00 |
| Value (Lacs) | 4,398.54 |
| VWAP | 201.99 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 26,864 |
| High | 205.28 |
| Low | 200.28 |
| UC Limit | 223.45 |
| LC Limit | 182.82 |
| 52 Week High | 307.90 |
| 52 Week Low | 181.73 |
| Face Value | 10.00 |
| All Time High | 307.90 |
| All Time Low | 63.10 |
| 20D Avg Volume | 4,236,915 |
| 20D Avg Delivery(%) | 28.18 |
| Book Value Per Share | 59.53 |
| Dividend Yield | 0.07 |
| TTM EPS See historical trend | 0.74 (+116.37% YoY) |
| TTM PE See historical trend | 273.11 (Average PE) |
| P/B See historical trend | 3.40 (Average P/B) |
| Sector PE | 39.68 |
*Delayed by 20 seconds.
Stock Score
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
3 out of 3 years Piramal Pharma has given positive returns in October.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| October | 17.23% (2024) | 8.45% | - | ` | 8.45% |
Trumpu2019s 100% drug tariff: A mixed bag for Indiau2019s CRDMO industry Sep 26 2025 10:13 PM
What does the new US Biosecure draft Act mean for the Indian CRDMO industry? Sep 15 2025 11:56 AM
Stocks to Watch Today: Titan, Bharti Airtel, Biocon, Cummins, BSE, LIC, KRBL, Metropolis, Kalpataru Projects, Godrej Consumer, Kalyan Jewellers, AU SFB in focus on 8 August Aug 08 2025 02:53 AM
Buy Piramal Pharma; target of Rs 265: ICICI Securities Jul 31 2025 11:28 AM
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 6856958 | Price 219.7 | % Traded 0.52 |
| Qty 6856958 | Price 219.88 | % Traded 0.52 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Piramal Pharma | 202.10 | -0.51 | 26,864.10 | 273.11 | 3.39 | 1.12 | -17.98 | 18 | 9,151 | 0.58 |
| Sun Pharma | 1,687.00 | -0.39 | 404,767.81 | 39.02 | 5.86 | 15.13 | -11.35 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,438.50 | -0.79 | 170,921.95 | 74.12 | 12.46 | 14.63 | 10.73 | 2,191 | 9,360 | 0.00 |
| Cipla | 1,568.10 | -1.00 | 126,665.74 | 23.49 | 4.47 | 16.90 | 4.32 | 5,291 | 27,547 | 0.00 |
| Torrent Pharma | 3,576.50 | -0.55 | 121,045.01 | 60.46 | 16.13 | 25.17 | 7.83 | 1,911 | 11,516 | 0.40 |